The Lupus Research Alliance applauds the decision by the U.S. Food and Drug Administration (FDA) to grant Breakthrough ...

Addiction is survival work, effective in the short run, but cyclical and costly over time. There is a way out.

How to go from resolution to solution Consistency over time matters more than intensity in the short term.”— Allison ...

YUVEZZI (TM) (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1% is a dual-agent eye drop approved by the U.S. Food & Drug Administration (FDA) for the treatment of presbyopia, a ...

Modern Health's peer-reviewed study shows meaningful reductions in depression and anxiety as well as gains in emotional skills following just 2-3 employee coaching sessions.

California Attorney General Rob Bonta has filed a lawsuit against the parent company of Children’s Hospital of Orange County ...

A morning exercise routine that relieves tension and restores alignment prepares your body for full weight-bearing movement so you can tackle daily demands.

The International Association of Top Professionals (IAOTP) will honor Stacey Schwizer at their annual awards gala in ...

Discusses Zydus Collaboration, Global Manufacturing Expansion, and Patient Access Initiatives January 28, 2026 4:00 PM ...

YUVEZZI (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1% is the only dual-agent presbyopia-correcting eye drop intentionally designed to deliver durability, tolerability, and safety ...

Considering what healthcare systems might learn from past efforts to develop highly trustworthy computer systems.

VANCOUVER, BC / ACCESS Newswire / January 29, 2026 / LIR Life Sciences Corp. (CSE:SKNY)(OTC PINK:BBCMF)(Frankfurt:N790, WKN:A41QA9) ("LIR" or the "Company")is pleased to announce positive interim resu ...